STOCK TITAN

GENAI ANNOUNCES DELAY IN FILING ITS ANNUAL FINANCIAL STATEMENTS AND ISSUANCE OF MCTO

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Generative AI Solutions Corp. (AICOF) has announced a delay in filing its annual financial statements for the year ended January 31, 2025. The delay is attributed to the external auditor's ongoing quality review of audit procedures, particularly concerning the accounting treatment of company acquisitions. The British Columbia Securities Commission has granted a Management Cease Trade Order (MCTO), which prohibits the CEO and CFO from trading company securities until the filings are complete. The company expects to file the required documents by June 30, 2025. The MCTO does not affect non-insider shareholders' ability to trade, and the company's shares will continue trading on the Canadian Securities Exchange. GenAI confirms no material undisclosed business developments and commits to providing bi-weekly default status reports until the situation is resolved.
Generative AI Solutions Corp. (AICOF) ha annunciato un ritardo nella presentazione del bilancio annuale relativo all'anno chiuso il 31 gennaio 2025. Il ritardo è dovuto alla revisione di qualità in corso da parte del revisore esterno, in particolare riguardo al trattamento contabile delle acquisizioni aziendali. La British Columbia Securities Commission ha emesso un Ordine di Sospensione delle Operazioni per il Management (MCTO), che vieta al CEO e al CFO di negoziare titoli della società fino al completamento delle presentazioni. L'azienda prevede di depositare i documenti richiesti entro il 30 giugno 2025. L'MCTO non influisce sulla capacità degli azionisti non insider di negoziare, e le azioni della società continueranno a essere scambiate sulla Canadian Securities Exchange. GenAI conferma l'assenza di sviluppi aziendali rilevanti non divulgati e si impegna a fornire rapporti bisettimanali sullo stato della situazione fino alla risoluzione del problema.
Generative AI Solutions Corp. (AICOF) ha anunciado un retraso en la presentación de sus estados financieros anuales correspondientes al año terminado el 31 de enero de 2025. El retraso se debe a la revisión de calidad en curso por parte del auditor externo, especialmente en relación con el tratamiento contable de las adquisiciones de la empresa. La Comisión de Valores de Columbia Británica ha emitido una Orden de Suspensión para la Gestión (MCTO), que prohíbe al CEO y al CFO negociar valores de la compañía hasta que se completen las presentaciones. La empresa espera presentar los documentos requeridos antes del 30 de junio de 2025. La MCTO no afecta la capacidad de los accionistas no insiders para negociar, y las acciones de la empresa continuarán cotizando en la Bolsa de Valores Canadiense. GenAI confirma que no hay desarrollos comerciales materiales no divulgados y se compromete a proporcionar informes quincenales sobre el estado de la situación hasta que se resuelva.
Generative AI Solutions Corp.(AICOF)는 2025년 1월 31일 종료된 회계연도 연례 재무제표 제출이 지연될 것이라고 발표했습니다. 이 지연은 외부 감사인의 감사 절차 품질 검토가 진행 중이며, 특히 회사 인수에 대한 회계 처리와 관련된 사항 때문입니다. 브리티시컬럼비아 증권위원회는 경영진 거래중지명령(MCTO)을 발령했으며, 이에 따라 CEO와 CFO는 제출이 완료될 때까지 회사 증권 거래가 금지됩니다. 회사는 2025년 6월 30일까지 필요한 서류를 제출할 예정입니다. MCTO는 내부자가 아닌 주주의 거래 능력에는 영향을 미치지 않으며, 회사 주식은 캐나다 증권거래소에서 계속 거래됩니다. GenAI는 중요 미공개 사업 개발 사항이 없음을 확인하며, 상황이 해결될 때까지 격주로 현황 보고서를 제공할 것을 약속합니다.
Generative AI Solutions Corp. (AICOF) a annoncé un retard dans le dépôt de ses états financiers annuels pour l'exercice clos le 31 janvier 2025. Ce retard est dû à la revue qualité en cours des procédures d'audit par l'auditeur externe, notamment concernant le traitement comptable des acquisitions d'entreprise. La British Columbia Securities Commission a émis une ordonnance de suspension des transactions pour la direction (MCTO), interdisant au PDG et au CFO de négocier les titres de la société jusqu'à la finalisation des dépôts. La société prévoit de déposer les documents requis d'ici le 30 juin 2025. La MCTO n'affecte pas la capacité des actionnaires non initiés à négocier, et les actions de la société continueront d'être échangées à la Bourse des valeurs canadienne. GenAI confirme qu'aucun développement commercial important non divulgué n'est en cours et s'engage à fournir des rapports d'état bi-hebdomadaires jusqu'à résolution de la situation.
Generative AI Solutions Corp. (AICOF) hat eine Verzögerung bei der Einreichung seiner Jahresfinanzberichte für das zum 31. Januar 2025 endende Geschäftsjahr angekündigt. Die Verzögerung ist auf die laufende Qualitätsprüfung der Prüfverfahren durch den externen Prüfer zurückzuführen, insbesondere im Hinblick auf die bilanzielle Behandlung von Unternehmensakquisitionen. Die British Columbia Securities Commission hat eine Management-Handelsaussetzungsverfügung (MCTO) erlassen, die dem CEO und CFO den Handel mit Unternehmenswertpapieren bis zur Fertigstellung der Einreichungen untersagt. Das Unternehmen erwartet, die erforderlichen Dokumente bis zum 30. Juni 2025 einzureichen. Die MCTO beeinträchtigt nicht die Handelbarkeit der Aktien für Nicht-Insider-Aktionäre, und die Aktien des Unternehmens werden weiterhin an der Canadian Securities Exchange gehandelt. GenAI bestätigt, dass keine wesentlichen nicht offengelegten Geschäftsentwicklungen vorliegen, und verpflichtet sich, bis zur Klärung der Situation zweiwöchentliche Statusberichte bereitzustellen.
Positive
  • Company remains operational and not subject to insolvency proceedings
  • Regular shareholders can continue trading shares
  • Company expects to complete filings by June 30, 2025
Negative
  • Delay in filing annual financial statements past deadline
  • MCTO restricts CEO and CFO from trading company securities
  • Issues with accounting treatment of company acquisitions requiring additional audit review

VANCOUVER, BC, June 3, 2025 /PRNewswire/ - Generative AI Solutions Corp. ("GenAI" or the "Company") (CSE: AICO) (OTCQB: AICOF) announces that due to a delay in the completion of audit and financial reporting procedures, GenAI did not file its audited annual financial statements, management's discussion and analysis and related certifications for the financial year ended January 31, 2025 on or before June 2, 2025, as required (the "Annual Filings").

The delay in filing the Annual Filings is outside of the Company's control and primarily due to the external auditor's quality review of audit procedures, including matters related to the accounting treatment and presentation of certain Company acquisitions in the financial statements. The Company is assisting their external auditor by providing then with the supplementary information and additional documentation they need in order to finalize their audit procedures, and it is anticipated that the Annual Finings will be made on or about June 30, 2025. The Company confirms that there have been no material business developments or other material information relating to its affairs as of the date of this news release that have not been generally disclosed and is not subject to any insolvency proceedings.

The Company requested the issuance of a management cease trade order ("MCTO") by the British Columbia Securities Commission (the "BCSC") under the provisions of National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). Further to the Company's request, the MCTO was today granted by the BCSC. The MCTO prohibits the chief executive officer and the chief financial officer of the Company from trading in securities of the Company for so long as the Annual Filings are not filed. During this period, the Company has undertaken not to, directly or indirectly, issue or acquire securities from an insider or employee of the Company. The MCTO does not affect the ability of any shareholders who are not insiders of the Company to trade their securities of the Company, and the Company's common shares will continue to trade on the Canadian Securities Exchange.

The Company confirms that it intends to satisfy the provisions of NP 12-203 and issue bi‑weekly default status reports for so long as the Company remains in default of the financial statement filing requirement, containing any material changes to the information in this release, all actions taken by the Company to remedy the default; particulars of any failure by the Company to fulfill these provisions, any subsequent defaults of the Company requiring a default announcement and any other material information concerning the affairs of the Company not previously disclosed.

On Behalf of the Board,

Patrick Gray
CEO, Director and Chairman of the Board

Generative AI Solutions Corp.
Toll-free North America: +1-833-879-7632
Outside North America: +1-406-879-7632
info@genai-solutions.com
www.genai-solutions.com

About Generative AI Solutions Corp.

GenAI is a pioneering artificial intelligence company focused on developing a vertically integrated AI solutions business through its proprietary MAI Cloudplatform, with the development and commercialization of AI-powered tools and solutions for businesses and consumers across multiple industries. At GenAI, our mission is to harness the power of AI to create transformative products and services that benefit business and consumers across various sectors. Our team of talented AI professionals and engineers are dedicated to developing state-of-the-art AI- based solutions that have broad applicability and can be seamlessly integrated into diverse workflows. By leveraging our MAI Cloudplatform and our expertise in machine learning, natural language processing, and data analytics, we build versatile high-performance tools that redefine efficiency, productivity, and user experience.

For more information on GenAI, please visit www.genai-solutions.com.

Forward-Looking Information and Statements

This news release contains "forward-looking statements" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved".

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company's ability to continue as a going concern; the Company's ability to continue to develop revenue generating applications; continued approval of the Company's activities by the relevant governmental and/or regulatory authorities; and the continued growth of the Company; and Company's ability to continue to meet the requirements of listing of the CSE.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/genai-announces-delay-in-filing-its-annual-financial-statements-and-issuance-of-mcto-302472541.html

SOURCE GENERATIVE AI SOLUTIONS CORP.

FAQ

Why did AICOF receive a Management Cease Trade Order (MCTO)?

AICOF received an MCTO due to delays in filing its annual financial statements for the year ended January 31, 2025, caused by the external auditor's ongoing quality review of audit procedures, particularly regarding company acquisitions.

When will Generative AI Solutions Corp. file its delayed annual financial statements?

The company expects to file its annual financial statements and related documents by June 30, 2025.

Can shareholders still trade AICOF stock during the MCTO period?

Yes, non-insider shareholders can continue trading AICOF shares. The MCTO only restricts trading by the company's CEO and CFO.

What is the current status of Generative AI Solutions Corp.'s business operations?

The company confirms it is operating normally, has no undisclosed material developments, and is not subject to any insolvency proceedings.

How will AICOF keep investors informed during the MCTO period?

The company will issue bi-weekly default status reports containing any material changes, actions taken to remedy the default, and other relevant information until the financial statements are filed.
Generative AI

OTC:AICOF

AICOF Rankings

AICOF Latest News

AICOF Stock Data

8.98M
67.79M
12.41%
Software - Application
Technology
Link
Canada
Vancouver